Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial by Mateo, Joaquin, MD, Porta, Nuria, PhD, Bianchini, Diletta, MD, McGovern, Ursula, MD, Elliott, Tony, MD, Jones, Robert, Prof, Syndikus, Isabel, MD, Ralph, Christy, MD, Jain, Suneil, MD, Varughese, Mohini, FRCR, Parikh, Omi, FRCR, Crabb, Simon, MBBS, Robinson, Angus, FRCR, McLaren, Duncan, MBBS, Birtle, Alison, MD, Tanguay, Jacob, MBCHB, Miranda, Susana, BSc, Figueiredo, Ines, BSc, Seed, George, MSc, Bertan, Claudia, MSc, Flohr, Penny, BSc, Ebbs, Berni, BSc, Rescigno, Pasquale, MD, Fowler, Gemma, BSc, Ferreira, Ana, MSc, Riisnaes, Ruth, FIBMS, Pereira, Rita, BSc, Curcean, Andra, MD, Chandler, Robert, MD, Clarke, Matthew, BSc, Gurel, Bora, MD, Crespo, Mateus, MSc, Nava Rodrigues, Daniel, MD, Sandhu, Shahneen, MBBS, Espinasse, Aude, MSc, Chatfield, Peter, BSc, Tunariu, Nina, MD, Yuan, Wei, PhD, Hall, Emma, Prof, Carreira, Suzanne, PhD, de Bono, Johann S, Prof

Get full text

Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes by Levelt, Eylem, MBBS, DPhil, Pavlides, Michael, MBBS, Banerjee, Rajarshi, BMBCh, DPhil, Mahmod, Masliza, DPhil, Kelly, Catherine, PhD, Sellwood, Joanna, BSc, Ariga, Rina, MBBS, BSc, Thomas, Sheena, PgC, BsC, BA, Francis, Jane, DCR(R), DNM, Rodgers, Christopher, MChem, DPhil, Clarke, William, MChem, Sabharwal, Nikant, BSc, BM, BCh, DM, Antoniades, Charalambos, MD, PhD, Schneider, Jurgen, PhD, Robson, Matthew, PhD, Clarke, Kieran, PhD, Karamitsos, Theodoros, MD, PhD, Rider, Oliver, BMBCh, DPhil, Neubauer, Stefan, MD

Get full text

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggreg... by Vale, Claire L, Dr, Burdett, Sarah, MSc, Rydzewska, Larysa H M, BSc, Albiges, Laurence, MD, Clarke, Noel W, Prof, Fisher, David, MSc, Fizazi, Karim, Prof, Gravis, Gwenaelle, MD, James, Nicholas D, Prof, Mason, Malcolm D, Prof, Parmar, Mahesh K B, Prof, Sweeney, Christopher J, MBBS, Sydes, Matthew R, CStat, Tombal, Bertrand, Prof, Tierney, Jayne F, PhD

Get full text

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Globa... by Wasan, Harpreet S, MRCP, Gibbs, Peter, MD, Sharma, Navesh K, FACRO, Taieb, Julien, Prof, Heinemann, Volker, Prof, Ricke, Jens, Prof, Peeters, Marc, Prof, Findlay, Michael, Prof, Weaver, Andrew, MD, Mills, Jamie, FRCR, Wilson, Charles, FRCR, Adams, Richard, Prof, Francis, Anne, DPhil, Moschandreas, Joanna, PhD, Virdee, Pradeep S, MSc, Dutton, Peter, MSc, Love, Sharon, BSc, Gebski, Val, Prof, Gray, Alastair, Prof, van Hazel, Guy, Prof, Sharma, Ricky A, Prof

Get full text

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial by James, Nicholas D, Prof, Sydes, Matthew R, CSci, Mason, Malcolm D, Prof, Clarke, Noel W, Prof, Anderson, John, MD, Dearnaley, David P, Prof, Dwyer, John, FRIC, Jovic, Gordana, PhD, Ritchie, Alastair WS, FRCSEd, Russell, J Martin, FRCR, Sanders, Karen, BSc, Thalmann, George N, Prof, Bertelli, Gianfilippo, MD, Birtle, Alison J, FRCR, O'Sullivan, Joe M, Prof, Protheroe, Andrew, PhD, Sheehan, Denise, FRCR, Srihari, Narayanan, FRCR, Parmar, Mahesh KB, Prof

Get full text

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial by Muers, Martin F, FRCP, Stephens, Richard J, Fisher, Patricia, FRCR, Darlison, Liz, BSc Hons, Higgs, Christopher MB, MD, Lowry, Erica, BA, Nicholson, Andrew G, Prof, O'Brien, Mary, MD, Peake, Michael, FRCP, Rudd, Robin, MD, Snee, Michael, DM, Steele, Jeremy, MD, Girling, David J, FRCP, Nankivell, Matthew, MSc, Pugh, Cheryl, BSc Hons, Parmar, Mahesh KB, Prof

Get full text

Effect of a novel vital sign device on maternal mortality and morbidity in low-resource settings: a pragmatic, stepped-wedge, cluster-randomised controlled trial by Vousden, Nicola, Lawley, Elodie, Nathan, Hannah L, Seed, Paul T, Gidiri, Muchabayiwa Francis, Goudar, Shivaprasad, Sandall, Jane, Chappell, Lucy C, Shennan, Andrew H, Kachinjika, Monice, Bukani, Doreen, Makwakwa, Jane, Makonyola, Grace, Brown, Adrian, Toussaint, Paul, Vixama, Adeline, Greene, Grace, Hill, Carwyn, Nakiriija, Emily, Birungi, Doreen, Kalyowa, Noela, Namakula, Dorothy, Byamugisha, Josaphat, Nakimuli, Annettee, Mackayi Odeke, Nathan, Ditai, James, Wandabwa, Julius, Momodou, Fatmata, Sesay, Margaret, Sandi, Patricia, Conteh, Jeneba, Kamara, Jesse, Clarke, Matthew, Best, Rebecca, Miti, Josephine, Kopeka, Mercy, Vwalika, Bellington, Chima, Martina, Musonda, Thokozile, Jere, Christine, Chinkoyo, Sebastian, Mambo, Violet, Guchale, Yonas, Yadeta, Lomi, Surur, Feiruz, Mungarwadi, Geetanjali M, Mastiholi, Sphoorthi S, Karadiguddi, Chandrappa C, Charantimath, Umesh, Bellad, Mrutyunjaya, Hezelgrave, Natasha, Duhig, Kate E

Get full text